Apoptosis: Mechanisms and clinical implications

Anaesthesia

Volumn 55, Issue 11, 2000, Pages 1081-1093

  Kam, P C A ^a   Ferch, N I ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Apoptosis; Cell death: morphology; mechanisms; clinical implications; Multiple organ dysfunction syndrome

Indexed keywords

APOPTOSIS; AUTOIMMUNE DISEASE; CANCER; CELL DEATH; DEGENERATIVE DISEASE; GENE CONTROL; HUMAN; ISCHEMIC HEART DISEASE; MORPHOLOGY; MULTIPLE ORGAN FAILURE; NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY MECHANISM; REVIEW; SEPSIS; STROKE; VIRUS INFECTION;

APOPTOSIS; BRAIN DISEASES; CARDIOVASCULAR DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; MULTIPLE ORGAN FAILURE;

EID: 0033692510     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2000.01554.x     Document Type: Review

References (148)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Apoptosis - The cell's silent exit
3. Apoptosis - Clinical relevance and pharmacological manipulation
4. Apoptosis and gastrointestinal pharmacology
5. Apoptosis, oncosis and necrosis - An overview of cell death
6. Eine neue Anschauung uber physiologische Zellausschaltung
7. Cell deaths in normal vertebrate ontogeny
8. Programmed cell death: Necrosis versus apoptosis
9. An electron-microscope study of liver cell necrosis due to Heliotrine
10. An electron-microscope study of liver cell necrosis due to Albitocin
11. Shrinkage necrosis: A distinct mode of cellular death
12. Cell death in the normal neonatal rat adrenal cortex
13. An electron microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells
14. Adrenocortical cell deletion: The role of ACTH
15. Chromatin changes in apoptosis
16. Genetic control of programmed cell death in the nematode Caenorhabditis elegans
17. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
18. Bcl-2 gene promotes haemopoetic cell survival and cooperates with C-myc to immortalize pre-B cells
19. The Fas death factor
20. Rodent fibroblast tumours expressing human myc and ras genes: Growth, metastasis and endogenous oncogene expression
21. Induction of apoptosis in fibroblasts by C-myc protein
22. Apoptosis: Suicide, execution or murder?
23. Nuclear changes in apoptosis
24. Chemical carcinogenesis
25. Defining apoptosis
26. Redefining cell death
27. Dose-dependent induction of apoptosis in human tumour cell lines by widely divergent stimuli
28. Mechanisms of cell injury and death
29. Post-embryonic cell lineages of the nematode C. elegans
30. Apoptosis in neurological disease
31. Apoptosis: Mechanisms and roles in pathology
32. Apoptosis: An overview
33. Apoptosis: Its nature and implications for dermatopathology
34. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
35. Apoptosis in endocrine glands
36. The role of DNA fragmentation in apoptosis
37. Identification of programmed cell death in situ via special labelling of nuclear DNA fragments
38. Adaptation of a simple flow cytometric assay to identify different stages during apoptosis
39. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry
40. A selective procedure for DNA extracting form apoptotic cells applicable for gel electrophoresis and flow cytometry
41. Apoptosis and disease: Regulation and clinical relevance of programmed cell death
42. Death by design - Programmed cell death in cardiovascular biology and disease
43. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis
44. Acid sphingomyelinase deficient lymphoblasts and mice are defective in radiation-induced apoptosis
45. Apoptosis and the heart
46. Prevention of programmed cell death in Caenorhabditis elegans by human Bcl-2
47. The Bcl-2 family of proteins
48. Involvement of the Bcl-2 gene in human follicular lymphoma
49. Cloning and structural analysis of cDNAs for Bcl-2 and a hybrid Bcl-2 immunoglobulin transcript resulting from the T (14; 18) translocation
50. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
51. Prevention of apoptosis by Bcl-2: Release of cytochrome C from mitochondria blocked
52. Apoptosis - Basic mechanisms and implications for cardiovascular disease
53. Apoptosis in the failing human heart
54. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene
55. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
56. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
57. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation
58. ICE/CED-3 proteases in apoptosis
59. Control of apoptosis by proteases
60. Involvement of an ICE-like protease in Fas-mediated apoptosis
61. The caspase family of cysteine proteases
62. Apoptosis: A potential role for cystosolic transglutaminase and its importance in tumour progression
63. Recognition and phagocytosis of cells undergoing apoptosis
64. Phagocytic docking without shocking
65. Granulocyte clearance by apoptosis in the resolution of inflammation
66. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
67. Human CD14 mediates recognition and phagocytosis of apoptotic cells
68. CNTF protection of oligodendrocytes against natural and tumour necrosis factor-induces death
69. Ionic dependence of glutamate neurotoxicity in cortical cell culture
70. Glutamate neurotoxicity in cortical cell culture
71. Glutamate triggers internucleosomal DNA cleavage in neuronal cells
72. Normal and abnormal calcium homeostasis in neurones: A basis for the pathophysiology of traumatic and ischaemic central nervous system injury
73. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischaemia
74. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat
75. Apoptosis is induced by -amyloid in cultured central nervous system neurones
76. Cell death induced by -amyloid 1-40 in MES 23.5 hybrid clone: The role of nitric oxide and NMDA-gated channel attraction leading to apoptosis
77. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors
78. The p53 gene and its role in human brain tumors
79. A recombinant bcl-xs adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells
80. Retroviral delivery and tetracycline-dependent expression of IL-1̄-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells
81. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
82. Reperfusion injury induced apoptosis in rabbit cardiomyocytes
83. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
84. Apoptosis in human atherosclerosis and restenosis
85. Normal and abnormal consequences of apoptosis in the human heart: From postnatal morphogenesis to paroxysmal arrhythmias
86. T-cell apoptosis detected in situ during positive and negative selection in the thymus
87. Programmed T lymphocyte death: Cell activation- and steroid-induced pathways are mutually antagonistic
88. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: A possible in vitro model for positive selection of the T cell repertoire
89. Apoptosis and the maintenance of homeostasis in the immune system
90. Apoptosis - Molecular mechanisms and biomedical implications
91. Mechanisms of autoantibody production and their role in disease
92. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosis
93. Apoptosis and the immune system
94. Granulocyte apoptosis and inflammatory disease
95. The role of apoptosis in the pathogenesis and treatment of diseases
96. Anti-apoptotic genes of baculovirus
97. Viruses and apoptosis
98. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1
99. AIDS and the death receptors
100. Multiple organ failure syndrome
101. The induction of accelerated thymic programmed cell death during polymicrobiol sepsis: Control by corticosteroids but not tumor necrosis factor
102. Human sepsis increases lymphocyte intracellular calcium
103. Superoxide anion generation in the liver during the early stage of endotoxaemia in rats
104. The pathophysiology of tumor necrosis factors
105. The biological properties of interleukin-1
106. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release
107. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1̄ and resistant to endotoxic shock
108. Differential induction of apoptosis in lymphoid tissues during sepsis: Variation in onset, frequency and nature of the mediators
109. Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T- and B-cell deficient mice
110. Sepsis-induced apoptosis of the thymocytes in mice
111. The role of programmed cell death (apoptosis) in thymic involution following sepsis
112. Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide
113. Listeria monocytogenes induce apoptosis of infected hepatocytes
114. Sir Isaac Newton, sepsis. SIRS and CARS
115. Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation
116. Pro-inflammatory cytokines regulate apoptosis of granulocytes during systemic inflammation
117. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome
118. Interleukin-10 counter-regulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis
119. Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation and nitric oxide release
120. Control of C-myc regulation in normal and neoplastic cells
121. Delivery of C-myc antisense phosphorothioate oligodeoxynucleotides to haematopoietic cells in culture by liposome fusion: Specific reduction in C-myc protein expression correlates with inhibition of cell growth and DNA synthesis
122. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by C-myc antisense oligonucleotides
123. Bcl-2 and the regulation of cell death
124. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis
125. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
126. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
127. Clinical implications of the p53 tumor suppressor gene
128. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells
129. P53 and apoptosis
130. Lymphocyte apoptosis induced by CD 45 (APO-1/fas) ligand-expressing tumour cells - A mechanism of immune-evasion?
131. Apoptosis and the kidney
132. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
133. Apoptosis and expression of the Bcl-2 proto-oncogene in the fetal and adult human kidney: Evidence for the contribution of bcl-2 expression to renal carcinogenesis
134. Inhibition of apoptosis during development of colorectal cancer
135. Induction of apoptosis by wild-type p53 in a human colon tumour-derived cell line
136. Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas
137. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
138. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen
139. Apoptosis as a mechanism of cell death in liver allograft rejection
140. Programmed cell death in the reproductive system
141. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
142. Bcl-2 gene enables rescue from in vitro myelosupression (bone marrow cell death) induced by chemotherapy
143. Effects of Bcl-2 antisense oligonucleotides on in vitro proliferation and survival of normal bone marrow progenitors and leukemic cells
144. In vitro and in vivo studies of ICE inhibitors
145. Apoptosis: Its significance in cancer and cancer therapy
146. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells
147. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
148. Eosinophil apoptosis and the resolution of airway inflammation in asthma